Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

Gene therapy - promise, pitfalls, and prognosis

Article Abstract:

Gene therapy has not yet been proven effective in treating many diseases, however it is only in its early stages of development. Gene therapy involves using viruses to deliver normal genes to cells with disease-causing genes. In spite of much enthusiasm about gene therapy, two 1995 studies showed that two current gene therapy techniques were not effective in treating Duchenne's muscular dystrophy and cystic fibrosis. However, gene therapy may yet become effective for a number of reasons. It is based on firm scientific fundamentals, and techniques of delivering genes to cells have been improved. For gene therapy to become successful, it must be used on appropriate diseases, deliver genes to several cells, and allow those genes to remain active for a long time. In the 1995 trials, the diseases involve cells throughout the body and the implanted genes were weakened by immune responses. New techniques might involve new delivery viruses and drugs that inhibit immune response.

Author: Leiden, Jeffrey M.
Publisher: Massachusetts Medical Society
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 1995

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Gene therapy for hemophilia

Article Abstract:

Gene therapy that does not use a virus may be an effective treatment for hemophilia. For the first time, measurable amounts of factor VIII were produced in six patients who received the treatment. Unfortunately, factor VIII levels decreased and were undetectable within 10 months.

Author: Miller, Daniel G., Stamatoyannopoulos, George
Publisher: Massachusetts Medical Society
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 2001

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Nonviral transfer of the gene encoding coagulation factor VIII in patients with severe hemophila A

Article Abstract:

A type of gene therapy that does not use viruses may be an effective treatment for hemophilia, according to a study of six patients. The gene was introduced into skin cells taken from the patient, which were grown in culture and then injected back into the patient.

Author: Roth, David A., Tawa, Nicholas E., Jr., O'Brien, Joanne M., Treco, Douglas A., Selden, Richard F.
Publisher: Massachusetts Medical Society
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 2001

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Editorial, Evaluation, Gene therapy, Care and treatment, Hemophilia
Similar abstracts:
  • Abstracts: Cell encapsulation: promise and progress. Immunotherapy of tumors with xenogeneic endothelial cells as a vaccine
  • Abstracts: Nutritional therapy in patients with liver cirrhosis. Study of the dietary fibre content in cocoa
  • Abstracts: Coronary-artery bypass surgery and the brain. Cell therapy for Parkinson's disease. Long-term effect of diabetes and its treatment on cognitive function
  • Abstracts: What's the diagnosis when facial swelling and paralysis develop? Intralesional corticosteroid injection for treatment of central giant-cell granuloma
  • Abstracts: Training logic: How the science of sets, reps and rest can speed your gains in the gym. Power surge
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.